Top

Published in:

01-03-2011

Gene expression in response to ionizing radiation and family history of gastric cancer

Authors: Francesca Marcon, Francesco Silvestrini, Ester Siniscalchi, Domenico Palli, Calogero Saieva, Riccardo Crebelli

Published in: Familial Cancer | Issue 1/2011

Abstract

Genes and molecular pathways involved in familial clustering of gastric cancer have not yet been identified. The purpose of the present study was to investigate gene expression changes in response to a cellular stress, and its link with a positive family history for this neoplasia. To this aim leukocytes of healthy first-degree relatives of gastric cancer patients and controls were challenged in vitro with ionizing radiation and gene expression evaluated 4 h later on microarrays with 1,800 cancer-related genes. Eight genes, mainly involved in signal transduction and cell cycle regulation, were differentially expressed in healthy relatives of gastric cancer cases. Functional class scoring by Gene Ontology classification highlighted two G-protein related pathways, implicated in the proliferation of neoplastic tissue, which were differentially expressed in healthy subjects with positive family history of gastric cancer. The relative expression of 84 genes related to these pathways was examined using the SYBR green-based quantitative real-time PCR. The results confirmed the indication of an involvement of G-protein coupled receptor pathways in GC familiarity provided by microarray analysis. This study indicates a possible association between familiarity for gastric cancer and altered transcriptional response to ionizing radiation.

Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4–S66CrossRefPubMed

Parkin DM (2004) International variation. Oncogene 23:6329–6340CrossRefPubMed

Jakszyn P, Gonzalez CA (2006) Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 12(27):4296–4303PubMed

Tsugane S, Sasazuki S (2007) Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10(2):75–83CrossRefPubMed

Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49:347–353CrossRef

(2002) Cancer incidence in five continents, volume VIII. IARC Sci Publ 155:1–781

Oliveira C, Seruca R, Carneiro F (2006) Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 14:21–33CrossRefPubMed

Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C et al (1994) Family history and risk of stomach cancer in Italy. Cancer Epiodemiol Biomark Prev 3:15–18

Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85CrossRefPubMed

10.

Yaghoobi M, Bijarchi R, Narod SA (2010) Family history and the risk of gastric cancer. Br J Cancer 102(2):237–242CrossRefPubMed

11.

Correa P, Schneider BG (2005) Etiology of gastric cancer: what is new? Cancer Epidemiol Biomark Prev 14:1865–1868CrossRef

12.

Perez-Perez GI, Garza-Gonzalez E, Portal C, Olivares AZ (2005) Role of cytokine polymorphisms in the risk of distal gastric cancer development. Cancer Epidemiol Biomark Prevent 14:1869–1873CrossRef

13.

Katoh M (2007) Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 6(6):832–839CrossRefPubMed

14.

Ding SZ, Smith MF Jr, Goldberg JB (2008) Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells. J Gastroenterol Hepatol 23(7 Pt 2):e67–e78CrossRefPubMed

15.

Asur R, Balasubramaniam M, Marples B, Thomas RA, Tucker JD (2010) Involvement of MAPK proteins in bystander effects induced by chemicals and ionizing radiation. Mutat Res 686(1–2):15–29PubMed

16.

Tsukimoto M, Tamaishi N, Homma T, Kojima S (2010) Low-dose gamma-ray irradiation induces translocation of Nrf2 into nuclear in mouse macrophage RAW264.7 cells. J Radiat Res 51(3):349–353

17.

Chuang EY, Chen X, Tsai MH, Yan H, Li CY, Mitchell JB, Nagasawa H, Wilson HF, Peng Y, Fitzek MM, Bedford JS, Little JB (2006) Abnormal gene expression profiles in unaffected parents of patients with hereditary-type retinoblastoma. Cancer Res 66:3428–3433CrossRefPubMed

18.

Weichselbaum RR, Hallahan DE, Sukhatme V, Dritschili A, Sherman ML, Kufe DW (1991) Biological consequences of gene regulation after ionizing radiation exposure. J Natl Cancer Inst 83(7):480–484CrossRefPubMed

19.

Maia AT, Spiteri I, Lee AJX, O’Reilly M, Jones L, Caldas C, Ponder BAJ (2009) Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. Breast Cancer Res 11:R88CrossRefPubMed

20.

Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S et al (1989) A case-control study of gastric cancer in Italy. Int J Cancer 44:611–616CrossRefPubMed

21.

D’Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, Palombo F, Giuliani A, Dogliotti E (2009) Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer 45:461–469CrossRefPubMed

22.

Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R et al (1992) Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89:3010–3014CrossRefPubMed

23.

Armstrong NJ, van de Wiel MA (2004) Microarray data analysis: from hypotheses to conclusions using gene expression data. Cell Oncol 26(5–6):279–290PubMed

24.

Wright GW, Simon R (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448–2455CrossRefPubMed

25.

Pavlidis P, Qin J, Arango V, Mann JJ, Sibille E (2004) Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29:1213–1222CrossRefPubMed

26.

Akerman GS, Rosenzweig BA, Domon OE, Tsai CA, Bishop ME, McGarrity LJ et al (2005) Alterations in gene expression profiles and the DNA-damage response in ionising radiation-exposed TK6 cells. Environ Mol Mutag 45:188–205CrossRef

27.

Coleman MA, Yin E, Peterson LE, Nelson D, Sorensen K, Tucker JD et al (2005) Low-dose irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptive response. Radiat Res 164:369–382CrossRefPubMed

28.

Turtoi A, Brown I, Oskamp D, Schneeweiss FHA (2008) Early gene expression in human lymphocytes after γ-irradiation—a genetic pattern with potential for biodosimetry. Int J Radiat Biol 84:375–387CrossRefPubMed

29.

van Delft MF, Huang DC (2006) How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16:203–213CrossRefPubMed

30.

Bishay K, Ory K, Lebeau J, Levalois C, Olivier MF, Chevillard S (2000) DNA damage-related gene expression as biomarkers to assess cellular response after gamma irradiation of a human lymphoblastoid cell line. Oncogene 19:916–923CrossRefPubMed

31.

Choi SA, Kim SJ, Chung KC (2006) Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations. FEBS Lett 580:5275–5282CrossRefPubMed

32.

Robles AI, Bemmels NA, Foraker AB, Harris CC (2001) APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 61:6660–6664PubMed

33.

Busto R, Shally AV, Varga JL, Garcia-Fernandez MO, Groot K, Armatis P et al (2002) The expression of GHRH and splice variants of its receptor in human gastroenteropancreatic carcinomas. Proc Natl Acad Sci USA 99:11866–11871CrossRefPubMed

34.

Yang S-K, Chen C (2007) Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes. Clin Exp Pharmacol Physiol 34:1221–1227CrossRefPubMed

35.

Jaïs P, Terris B, Ruszniewski P, LeRomancer M, Reyl-Desmars F, Vissuzaine C, Cadiot G, Mignon M, Lewin MJ (1997) Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. Eur J Clin Invest 27(8):639–644CrossRefPubMed

36.

Liang B, Wang S, Yang X, Ye Y, Yu Y, Cui Z (2003) Expression of cyclin E, Cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer. Chin Med J 116:20–23PubMed

37.

Shin JY, Kim HS, Lee KS, Kim J, Park JB, Won MH et al (2000) Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer. Exp Mol Med 32:79–83PubMed

38.

Yu J, Miehlke S, Ebert MP, Szokodi D, Wehvnignh B, Malfertheiner P, Ehninger G, Bayerdoerffer E (2002) Expression of cyclin genes in human gastric cancer and in first degree relatives. Chin Med J Engl 115:710–715PubMed

39.

Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J, Sung JJ (2010) Dysregulation of cellular signaling in gastric cancer. Cancer Lett 295(2):144–153CrossRefPubMed

40.

Stachowska E, Dolegowska B, Dziedziejko V, Rybicka M, Kaczmarczyk M, Bober J, Rac M, Machalinski B, Chlubek D (2009) Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages. J Physiol Pharmacol 60:77–85PubMed

41.

Zhang JT, Wang MW, Zhu ZL, Huo XH, Chu JK, Cui DS, Qiao L, Yu J (2005) Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients. World J Gastroenterol 11:4918–4922PubMed

42.

Oshima H, Oshima M, Inaba K, Taketo MM (2004) Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 23:1669–1678CrossRefPubMed

43.

Muller-Decker K, Furstenberger G (2007) The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis. Mol Carcinogen 46:705–710CrossRef

44.

Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M (2006) Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 131:1086–1095CrossRefPubMed

45.

Rozengurt E (2007) Mitogenic signalling pathways induced by G protein-coupled receptors. J Cell Physiol 213:589–602CrossRefPubMed

46.

Huang SL, Shyu RY, Yeh MY, Jiamg SY (2002) The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res 22:799–804PubMed

47.

Kohzuki M, Tanda S, Hori K, Suzuki M, Yoshida K, Sato T (2000) Decreased binding sites of angiotensin II in rat LY-80 and AH109A tumour and human gastric cancer using quantitative in vitro autoradiography. Int Angiol 19:52–58PubMed

48.

Nakamura A, Yamatani T, Arima N, Yamashita Y, Fujita T, Chiba T (1992) Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III. Regul Pept 37:183–194CrossRefPubMed

49.

Duffy MJ (2004) The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des 10:39–49CrossRefPubMed

50.

Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, Cheng LL, Lee J, Rha SY, Chung HC, Ganesan K, So J, Soo KC, Lim D, Chan WH, Wong WK, Bowtell D, Yeoh KG, Grabsch H, Boussioutas A, Tan P (2009) Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genetics 5(10):e1000676

51.

Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM (2008) Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer. Pancreas 36:173–177CrossRefPubMed

52.

Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev 7:79–94CrossRef

53.

Evers BM (2005) Gastrointestinal growth factors and neoplasia. Am J Surger 190:279–284CrossRef

54.

Thomas RP, Hellmich MR, Towsend CM, Evers BM (2007) Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocr Rev 24:571–599CrossRef

55.

Wood CD, Thornton TM, Sabio G, Davis RA, Rincon M (2009) Nuclear localization of p38 MAPK in response to DNA damage. Int J Biol Sci 5(5):428–437PubMed

56.

Weichselbaum RR, Hallahan DE, Sukhatme V, Dritschilo A, Sherman ML, Kufe DW (1991) Biological consequences of gene regulation after ionizing radiation exposure. Natl Cancer Inst 83(7):480–484CrossRef

57.

Marcon F, Palli D, Zufferli A, Mazzoli E, Siniscalchi E, Sera F, Saieva C, Crebelli R (2009) Evaluation of radiation-induced chromosome instability in subjects with a family history of gastric cancer. Biomarkers 14:226–234CrossRefPubMed

58.

Yan G-R, Chen N-P, Huang Y-D, Ding W, Gui-Wei H, Xiao C-L, Yin X-F, He Q-Y (2010) Signaling networks in gastric cancer cells revealed by phosphoproteomics. J Proteomics Bioinfor 3(4):113–120CrossRef

59.

Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS (2002) Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289–293CrossRefPubMed

60.

Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10:789–799CrossRefPubMed

61.

Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15:28–32CrossRefPubMed

62.

Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004) WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet 5:691–701CrossRefPubMed

63.

Shao J, Jung C, Liu C, Sheng H (2005) Prostaglandin E2 Stimulates the β-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 280:26565–26572CrossRefPubMed

64.

Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3:582–591CrossRefPubMed

65.

Lee Z, Swaby RF, Liang Y, Yu S, Liu S, Lu KH, Bast RC Jr, Mills GB, Fang X (2006) Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res 66:2740–2748CrossRefPubMed

66.

Jones SA, Moser B, Thelen M (1995) A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2. Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEBS Lett 364(2):211–214CrossRefPubMed

67.

Yang J, Zhang X, Wang W, Liu J (2010) Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells. Cell Biochem Funct 28(4):334–341CrossRefPubMed

68.

Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG (2009) p57^KIP2: “Kip”ing the cell under control. Mol Cancer Res 7(12):1902–1919CrossRefPubMed

69.

Chang TS, Kim MJ, Ryoo K et al (2003) p57^KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem 278:48092–48098CrossRefPubMed

Title: Gene expression in response to ionizing radiation and family history of gastric cancer
Authors: Francesca Marcon
Francesco Silvestrini
Ester Siniscalchi
Domenico Palli
Calogero Saieva
Riccardo Crebelli
Publication date: 01-03-2011
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 1/2011
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-010-9396-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

Colorectal cancer: no longer the issue in familial adenomatous polyposis?

Strictly defined familial male breast cancer

Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype

Cancer survivors: familial risk perception and management advice given to their relatives

An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models

Keynote webinar | Spotlight on antibody–drug conjugates in cancer